Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart surgery bleeding breakthrough: personalized dosing could save lives

NCT ID NCT07425600

Not yet recruiting Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Saint Etienne Source: ClinicalTrials.gov ↗

First seen Feb 28, 2026 · Last updated May 10, 2026 · Updated 9 times

Summary

This study looks at how to give the right amount of a blood-clotting medicine called fibrinogen to people who have heart surgery. Bleeding after heart surgery is a serious problem, and doctors want to find the best dose for each patient. The study will involve 150 adults and use blood tests to see how the body responds to different doses.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBRINOGEN DEFICIENCY IN COMPLEX CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Lille

    Lille, 59000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU de Saint-Etienne

    Saint-Etienne, 42000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

FIBRINOGEN DEFICIENCY IN COMPLEX CARDIAC SURGERY